Abstract
The advent and adaptation of many imaging modalities promise to revolutionize our understanding of retinopathy of prematurity (ROP) by improving the detection, diagnosis, and monitoring of response to treatment of this disease. Diagnosis and classification of ROP traditionally relies on an eye exam by an ophthalmologist expert in this area who characterizes extent and character of retinal vascularization via indirect ophthalmoscopy. Many tools now exist that allow for data acquisition by nurses, technicians, and other trained staff with the images analyzed in a more centralized location. We will focus on two rapidly evolving technologies, optical coherence tomography (OCT), and wide field fluorescein angiography (FA), to better understand how these tools may change our current understanding and management of ROP.